Correale, Jorge

Buenos Aires | Argentina
Name: Jorge Correale MD
Affiliation: Head of Neuroimmunology and Demyelinating Diseases
FLENI
Institute for Neurological Research “Dr. Raúl Carrea”

Dr. Jorge Correale graduated with honors from the Faculty of Medicine, University of Buenos Aires, in 1981. Between 1983 and 1988 he completed the residency of Neurology at the Dr. José María Ramos Mejía Hospital, Buenos Aires, and was appointed Chief of Residents.  During the year 1989 he collaborated in the Department of Neuropathology, in the same center. Dr. Correale continued his training as a fellow in Neuroimmunology at the Karolinska Institute in Stockholm, Sweden, between 1989 and 1990. In 1990 he moved to the United States, where he completed a second three-year fellowship in Neuroimmunology at the University of Southern California, with support of the National Multiple Sclerosis Society USA. In 1993 he was appointed Assistant Professor of Neurology at the University of Southern California, and in 1995 Assistant Professor of Microbiology and Molecular Immunology. In 1997, Dr. Correale returned to Buenos Aires as Head of Neuroimmunology and Demyelinating Diseases at the Neurological Research Institute Dr. Raúl Carrea, a position he currently holds, where he develops an intense assistance task in the evaluation and follow-up of patients with MS. Between 1999 and 2001 Dr. Correale was Head of the Department of Neurology of the same institution. Between 1998 and 2010 he was Associate Professor at the Austral University in Buenos Aires, teaching Clinical Neurophysiology, Physiopathology and Pain Treatment, and Neurology.

The main objective of Dr Correale’s work is to elucidate the role of environmental factors that determine the development or progression of Multiple Sclerosis, understanding the immunological mechanisms implicated. Additionally, the working group of Dr. Correale is focused on evaluating the clinical and immunological variations that are unleashed in particular circumstances of patients with multiple sclerosis such as assisted fertilization, pregnancy and puerperium, as well as the role that sex hormones play in each of these situations. The work of the Dr Correale Group has also led in the last years to the description of different cellular populations that regulate the immunity in Multiple Sclerosis that could condition the development of the disease.  Since 2013 Dr Correale is working at the School of Pharmacy and Biochemistry of the University of Buenos Aires in the biology of glial cells, with the aim of developing models that allow a better understanding of the processes involved in demyelination and remyelination. Dr Correale is a member of the editorial board of different journals of Neurology and Immunology, and he participates in the scientific review panels of the Multiple Sclerosis societies of Italy, the United Kingdom, Ireland, the Netherlands, Australia, and France, collaborating nationally in the evaluation of scientific projects of the Agency for Scientific and Technological Promotion and the Secretary of Science and Technology of the University of Buenos Aires.

Currently, Dr. Correale is a member of the Argentine Medical Advisory Council for Multiple Sclerosis, and member of the Medical and Scientific Board of the MSIF.  He has been former  Vice President and President of the Argentine Neurological Society, between 2008-2012, President of the Latin American Society for the Study and Treatment of Multiple Sclerosis (LACTRIMS) during the period 2014-2016, and member of the Advisory Board of the International Society of Neuroimmunology (ISNI).He is an active member of the Abstracts Review Committee of the European Committee for the Study and Treatment of Multiple Sclerosis (ECTRIMS), as well as the Committee for the Evaluation of Clinical Research Projects of the Progressive Multiple Sclerosis Alliance. He is currently co-Chair of the Subcommittee on Access to Medicines of the IFMSS, and member of the International Advisory Committee on Clinical Trials of  New Drugs in MS. Dr. Correale is the author of 180 articles published in prestigious journals of Neurology and Immunology, 250 abstracts presented at different international forums in Europe, USA and Canada, 46 chapters in books on Neurology, Multiple Sclerosis and Neuroimmunology, and published as an editor or co-editor 7 books related to Neurology, Multiple Sclerosis and Neuroimmunology.

All sessions

Afternoon Session

23 Sep 2019
16:30 - 19:00
Auditorium

Pathogenic anti-CNS antibodies

26 Sep 2019
8:45 - 9:30